Literature DB >> 17350758

Significant correlation between plasma and CSF anticholinergic activity in presurgical patients.

Konstanze Plaschke1, Christine Thomas, Ria Engelhardt, Peter Teschendorf, Ute Hestermann, Markus A Weigand, Eike Martin, Juergen Kopitz.   

Abstract

Previous studies have suggested a possible link between cognitive impairment and anticholinergic burden as reflected by high serum anticholinergic activity (SAA). Thus, we hypothesized a close relationship between anticholinergic activity in cerebral spinal fluid (CSF) and blood. However, it has never been convincingly demonstrated that peripheral anticholinergic activity correlates with central anticholinergic levels in presurgical patients. Therefore, anticholinergic activity was measured in blood and CSF from 15 patients with admission scheduled for urological surgery to compare peripheral and central anticholinergic level. Blood and CSF probes were taken after routine premedication and before spinal anesthesia. Anticholinergic activity was determined by competitive radioreceptor binding assay for muscarinergic receptors. Correlation analysis was conducted for peripheral and central anticholinergic levels. The mean anticholinergic levels were 2.4+/-1.7 in the patients' blood and 5.9+/-2.1 pmol/mL of atropine equivalents in CSF. Interestingly, the anticholinergic activity in CSF was about 2.5-fold higher than in patients' blood. A significant linear correlation was detected between blood and CSF levels. Therefore we conclude that SAA levels adequately reflect central anticholinergic activity. When patients receiving or not receiving anticholinergic medication were compared, anticholinergic activity tended to increase in blood and CSF after receiving anticholinergic medication > or =4 weeks (p>0.05).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350758     DOI: 10.1016/j.neulet.2007.02.015

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

Review 2.  [Delirium in the intensive care unit].

Authors:  R von Haken; M Gruss; K Plaschke; M Scholz; R Engelhardt; A Brobeil; E Martin; M A Weigand
Journal:  Anaesthesist       Date:  2010-03       Impact factor: 1.041

Review 3.  Biomarkers of postoperative delirium and cognitive dysfunction.

Authors:  Ganna Androsova; Roland Krause; Georg Winterer; Reinhard Schneider
Journal:  Front Aging Neurosci       Date:  2015-06-09       Impact factor: 5.750

4.  Reduction in the rate of postoperative delirium by switching from famotidine to omeprazole in Japanese hepatectomized recipients.

Authors:  Miho Yamasaki; Yusa Fukuda; Aika Tanimoto; Miko Narahara; Yumi Kawaguchi; Hiromi Ushiroda; Saburo Fukuda; Teruo Murakami; Yorinobu Maeda
Journal:  J Pharm Health Care Sci       Date:  2019-05-07

5.  The effect of neostigmine on postoperative delirium after colon carcinoma surgery: a randomized, double-blind, controlled trial.

Authors:  Fanghao Liu; Xu Lin; Yanan Lin; Xiyuan Deng; Yuwei Guo; Bin Wang; Rui Dong; Yanlin Bi
Journal:  BMC Anesthesiol       Date:  2022-08-22       Impact factor: 2.376

6.  Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium.

Authors:  Christine Thomas; Ute Hestermann; Juergen Kopitz; Konstanze Plaschke; Peter Oster; Martin Driessen; Christoph Mundt; Matthias Weisbrod
Journal:  BMC Neurosci       Date:  2008-09-15       Impact factor: 3.288

Review 7.  Serum anticholinergic activity: a possible peripheral marker of the anticholinergic burden in the central nervous system in Alzheimer's disease.

Authors:  Koji Hori; Kimiko Konishi; Masayuki Tani; Hiroi Tomioka; Ryo Akita; Yuka Kitajima; Mari Aoki; Sachiko Yokoyama; Kazunari Azuma; Daisuke Ikuse; Norihisa Akashi; Misa Hosoi; Koichi Jinbo; Mitsugu Hachisu
Journal:  Dis Markers       Date:  2014-02-09       Impact factor: 3.434

Review 8.  Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature.

Authors:  Mohammed Saji Salahudeen; Te-Yuan Chyou; Prasad S Nishtala
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

9.  Endogenous CHRNA7-ligand SLURP1 as a potential tumor suppressor and anti-nicotinic factor in pancreatic cancer.

Authors:  Verena M Throm; David Männle; Thomas Giese; Andrea S Bauer; Matthias M Gaida; Juergen Kopitz; Thomas Bruckner; Konstanze Plaschke; Svetlana P Grekova; Klaus Felix; Thilo Hackert; Nathalia A Giese; Oliver Strobel
Journal:  Oncotarget       Date:  2018-01-24

Review 10.  Adaptation of the Pharmacological Management of Delirium in ICU Patients in Iran: Introduction and Definition.

Authors:  Mohammad Arbabi; Fatemeh Shahhatami; Mojtaba Mojtahedzadeh; Mostafa Mohammadi; Padideh Ghaeli
Journal:  Iran J Psychiatry       Date:  2018-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.